Weatherly Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $20.2M | Sell |
158,095
-130
| -0.1% | -$16.2K | 1.63% | 19 |
|
|
2025
Q4 | $19.3M | Buy |
158,225
+2,486
| +2% | +$285K | 1.48% | 19 |
|
|
2025
Q3 | $15.6M | Sell |
155,739
-760
| -0.5% | -$68.5K | 1.29% | 20 |
|
|
2025
Q2 | $13M | Sell |
156,499
-651
| -0.4% | -$51.9K | 1.11% | 21 |
|
|
2025
Q1 | $12.7M | Sell |
157,150
-795
| -0.5% | -$71.1K | 1.14% | 22 |
|
|
2024
Q4 | $14.2M | Buy |
157,945
+532
| +0.3% | +$51.5K | 1.26% | 21 |
|
|
2024
Q3 | $15.6M | Sell |
157,413
-2,266
| -1% | -$223K | 1.36% | 20 |
|
|
2024
Q2 | $14.8M | Sell |
159,679
-2,672
| -2% | -$240K | 1.36% | 19 |
|
|
2024
Q1 | $15.4M | Sell |
162,351
-3,266
| -2% | -$303K | 1.49% | 17 |
|
|
2023
Q4 | $14.8M | Sell |
165,617
-5,033
| -3% | -$374K | 1.59% | 16 |
|
|
2023
Q3 | $12.5M | Sell |
170,650
-4,272
| -2% | -$341K | 1.49% | 17 |
|
|
2023
Q2 | $14.6M | Sell |
174,922
-10,064
| -5% | -$842K | 1.7% | 14 |
|
|
2023
Q1 | $14.1M | Sell |
184,986
-2,950
| -2% | -$245K | 1.83% | 12 |
|
|
2022
Q4 | $15.6M | Sell |
187,936
-1,898
| -1% | -$154K | 2.13% | 11 |
|
|
2022
Q3 | $15.1M | Sell |
189,834
-483
| -0.3% | -$40.7K | 2.16% | 10 |
|
|
2022
Q2 | $14.1M | Sell |
190,317
-7,590
| -4% | -$570K | 1.97% | 11 |
|
|
2022
Q1 | $17.8M | Buy |
197,907
+5,130
| +3% | +$474K | 2.08% | 11 |
|
|
2021
Q4 | $21.6M | Buy |
192,777
+4,223
| +2% | +$509K | 2.39% | 8 |
|
|
2021
Q3 | $23.7M | Buy |
188,554
+4,610
| +3% | +$594K | 2.88% | 7 |
|
|
2021
Q2 | $24.9M | Buy |
183,944
+2,989
| +2% | +$393K | 3.14% | 7 |
|
|
2021
Q1 | $24.5M | Buy |
180,955
+1,105
| +0.6% | +$165K | 3.41% | 6 |
|
|
2020
Q4 | $25.3M | Buy |
179,850
+2,598
| +1% | +$333K | 3.64% | 6 |
|
|
2020
Q3 | $19.8M | Buy |
177,252
+7,111
| +4% | +$797K | 3.19% | 6 |
|
|
2020
Q2 | $19M | Buy |
170,141
+6,401
| +4% | +$630K | 3.37% | 6 |
|
|
2020
Q1 | $12.7M | Buy |
163,740
+4,063
| +3% | +$360K | 2.77% | 8 |
|
|
2019
Q4 | $15.2M | Buy |
159,677
+6,913
| +5% | +$598K | 2.9% | 7 |
|
|
2019
Q3 | $11.6M | Sell |
152,764
-6,260
| -4% | -$520K | 2.48% | 9 |
|
|
2019
Q2 | $13.9M | Buy |
159,024
+3,772
| +2% | +$322K | 2.78% | 6 |
|
|
2019
Q1 | $14.1M | Buy |
155,252
+5,433
| +4% | +$462K | 2.87% | 6 |
|
|
2018
Q4 | $10.8M | Buy |
149,819
+1,927
| +1% | +$155K | 2.55% | 6 |
|
|
2018
Q3 | $14.2M | Buy |
147,892
+3,693
| +3% | +$358K | 2.91% | 6 |
|
|
2018
Q2 | $13.7M | Buy |
144,199
+1,765
| +1% | +$162K | 3.2% | 5 |
|
|
2018
Q1 | $12.5M | Buy |
142,434
+6,874
| +5% | +$628K | 2.96% | 6 |
|
|
2017
Q4 | $11.5M | Buy |
135,560
+3,119
| +2% | +$261K | 2.78% | 6 |
|
|
2017
Q3 | $11.5M | Buy |
132,441
+6,904
| +5% | +$553K | 3.04% | 6 |
|
|
2017
Q2 | $9.69M | Buy |
125,537
+5,374
| +4% | +$381K | 2.73% | 5 |
|
|
2017
Q1 | $8.33M | Buy |
120,163
+4,430
| +4% | +$298K | 2.46% | 7 |
|
|
2016
Q4 | $6.85M | Buy |
115,733
+9,422
| +9% | +$582K | 2.18% | 9 |
|
|
2016
Q3 | $7.05M | Buy |
106,311
+2,600
| +3% | +$161K | 2.34% | 7 |
|
|
2016
Q2 | $5.61M | Buy |
103,711
+9,127
| +10% | +$500K | 1.85% | 12 |
|
|
2016
Q1 | $4.89M | Buy |
94,584
+8,545
| +10% | +$444K | 1.69% | 14 |
|
|
2015
Q4 | $6.04M | Buy |
86,039
+5,883
| +7% | +$401K | 2.14% | 10 |
|
|
2015
Q3 | $4.99M | Buy |
80,156
+41
| +0.1% | +$3.23K | 2.02% | 10 |
|
|
2015
Q2 | $6.74M | Buy |
80,115
+6,171
| +8% | +$480K | 2.57% | 7 |
|
|
2015
Q1 | $5.56M | Sell |
73,944
-5,538
| -7% | -$387K | 2.22% | 8 |
|
|
2014
Q4 | $4.94M | Buy |
79,482
+4,047
| +5% | +$231K | 2.07% | 10 |
|
|
2014
Q3 | $3.92M | Buy |
75,435
+2,697
| +4% | +$138K | 1.69% | 13 |
|
|
2014
Q2 | $3.73M | Buy |
72,738
+3,570
| +5% | +$161K | 1.56% | 14 |
|
|
2014
Q1 | $3.29M | Buy |
69,168
+7,704
| +13% | +$394K | 1.52% | 16 |
|
|
2013
Q4 | $2.67M | Buy |
61,464
+25,377
| +70% | +$1.05M | 1.27% | 23 |
|
|
2013
Q3 | $1.55M | Buy |
36,087
+29,190
| +423% | +$1.18M | 0.79% | 38 |
|
|
2013
Q2 | $240K | Buy |
+6,897
| New | +$242K | 0.13% | 115 |
|
Other funds holding XBI
Weatherly Asset Management's XBI Position: Q1 2026 in Review
Weatherly Asset Management reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 0.08% in Q1 2026, selling an estimated $16.2K and leaving 158,095 shares worth $20.2M. The position accounts for 1.63% of the portfolio, ranked #19.
Weatherly Asset Management first reported a position in XBI in Q2 2013 and has held it in 52 quarters since. The position peaked at $25.3M in Q4 2020. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Weatherly Asset Management held 158,095 shares of State Street SPDR S&P Biotech ETF worth $20.2M as of Q1 2026.
- Weatherly Asset Management sold 130 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $16.2K.
- State Street SPDR S&P Biotech ETF made up 1.63% of Weatherly Asset Management's portfolio in Q1 2026, its #19 holding.
- Weatherly Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 52 quarters since.
- Weatherly Asset Management's State Street SPDR S&P Biotech ETF position peaked at $25.3M in Q4 2020.
- 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Weatherly Asset Management's 13F filing for Q1 2026, filed 15 Apr 2026.